Santagostino E, Gringeri A, Cultraro D, Tradati F, Siracusano L, Marinoni A, Mannucci P M
A. Bianchi Bonomi Hemophilia and Thrombosis Center, Institute of Internal Medicine, IRCCS Maggiore Hospital, University of Milan, Italy.
Cell Mol Biol (Noisy-le-grand). 1995 May;41(3):371-80.
Progression to AIDS and death were evaluated in 112 patients, 84 with hemophilia A and 28 with hemophilia B. Seroconversion period and age at seroconversion were similar in both groups. 36/112 patients died: 21/84 with hemophilia A (25%) and 15/28 (54%) with hemophilia B. Mean survival time was 11.7 years. The 10-year cumulative survival was 75.8%. It was lower in hemophilia B (56.2%) compared to hemophilia A patients (82.4%; p = 0.002). 37 patients (33%) developed full-blown AIDS: 26 with hemophilia A (31%) and 11 with hemophilia B (39%). Mean AIDS-free survival time was 11.4 years. The 10-year cumulative AIDS-free survival was 71.2%. It was 74.8% in hemophilia A and 60.3% in hemophilia B patients. CD4 counts lower than 200/cmm occurred in 62 patients (56%): 45 with hemophilia A (54%) and 17 with hemophilia B (63%). The mean time to CD4 counts lower than 200 was 9.4 years. Mean survival time in older seroconverters (35 year old or more) was shorter than in younger (9.5 vs. 11.7 years, p < 0.05). Mean CD4 cell counts at seroconversion were similar in hemophilia A and B patients and in different age classes at seroconversion. CD4 cell counts at seroconversion affected the survival: 90% seroconverters with CD4 cell counts of 800/cmm or more were alive at 10 years vs. 60% of seroconverters with CD4 cell counts lower than 800 (p < 0.05).
对112名患者的艾滋病进展情况和死亡情况进行了评估,其中84名患有甲型血友病,28名患有乙型血友病。两组的血清转化期和血清转化时的年龄相似。112名患者中有36人死亡:84名甲型血友病患者中有21人(25%)死亡,28名乙型血友病患者中有15人(54%)死亡。平均生存时间为11.7年。10年累积生存率为75.8%。与甲型血友病患者(82.4%;p = 0.002)相比,乙型血友病患者的10年累积生存率(56.2%)更低。37名患者(33%)发展为典型艾滋病:26名甲型血友病患者(31%)和11名乙型血友病患者(39%)。无艾滋病平均生存时间为11.4年。10年累积无艾滋病生存率为71.2%。甲型血友病患者的这一比例为74.8%,乙型血友病患者为60.3%。62名患者(56%)的CD4细胞计数低于200/cmm:45名甲型血友病患者(54%)和17名乙型血友病患者(63%)。CD4细胞计数低于200的平均时间为9.4年。血清转化时年龄较大(35岁及以上)的患者的平均生存时间短于年龄较小的患者(9.5年对11.7年,p < 0.05)。甲型和乙型血友病患者以及血清转化时不同年龄组的血清转化时CD4细胞计数相似。血清转化时的CD4细胞计数影响生存情况:血清转化时CD4细胞计数为800/cmm或更高的患者中,90%在10年后仍存活,而CD4细胞计数低于800的患者中这一比例为60%(p < 0.05)。